5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 26.70▲ | 26.65▲ | 26.65▲ | 26.97▲ | 25.99▲ |
MA10 | 26.43▲ | 26.37▲ | 26.35▲ | 26.54▲ | 24.91▲ |
MA20 | 26.15▲ | 25.95▲ | 25.91▲ | 26.18▲ | 22.99▲ |
MA50 | 25.76▲ | 25.45▲ | 25.16▲ | 24.86▲ | 21.34▲ |
MA100 | 23.72▲ | 23.38▲ | 23.08▲ | 22.92▲ | 20.18▲ |
MA200 | 22.00▲ | 21.76▲ | 21.54▲ | 21.65▲ | 21.97▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.065▲ | 0.068▲ | 0.054▲ | 0.074▲ | 0.406▲ |
RSI | 67.989▲ | 67.051▲ | 67.565▲ | 70.499▲ | 76.639▲ |
STOCH | 80.949▲ | 89.627▲ | 89.126▲ | 90.652▲ | 86.783▲ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -6.452▲ | -2.936▲ |
CCI | 197.556▲ | 194.912▲ | 182.267▲ | 152.854▲ | 151.246▲ |
Friday, August 15, 2025 05:12 AM
Q2 2025 Earnings Call Transcript August 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.28. Operator: Hello, and thank you for standing ...
|
Thursday, August 14, 2025 10:44 PM
The UK will lift its retail ban on crypto exchange-traded notes in October, reopening regulated access to bitcoin via FCA-approved investment exchanges.
|
Thursday, August 14, 2025 12:38 AM
Allogene Therapeutics Inc (ALLO) showcases significant progress in clinical trials and maintains a strong cash position, despite facing safety concerns and financial hurdles.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 27.65 | 27.65 | 27.34 | 27.47 | 6,000 |
14/08/25 | 27.50 | 27.50 | 26.91 | 27.02 | 7,400 |
13/08/25 | 27.11 | 27.19 | 26.81 | 27.19 | 12,300 |
12/08/25 | 26.61 | 26.79 | 26.42 | 26.79 | 4,500 |
11/08/25 | 26.62 | 26.62 | 26.23 | 26.38 | 4,300 |
08/08/25 | 26.50 | 26.73 | 26.50 | 26.62 | 4,400 |
07/08/25 | 26.59 | 26.59 | 25.94 | 26.16 | 12,500 |
06/08/25 | 26.14 | 26.15 | 26.02 | 26.15 | 2,000 |
05/08/25 | 26.13 | 26.26 | 25.75 | 25.99 | 15,364 |
04/08/25 | 25.80 | 25.80 | 25.32 | 25.67 | 18,100 |
|
|
||||
|
|
||||
|
|